Vir Biotechnology (VIR) Stock Forecast & Price Target

VIR$9.96-2.16 -17.82%
BiotechnologyGrowth Stock
Compare
Market cap$1.71BEnterprise value$1.85BRevenue (TTM)$302.80MMarket position—

Score

64
Neutral
Value
46
Quality
46
Growth
100

Vir Biotechnology, Inc. price target

VIR
Low$22.00
Average$23.50
High$25.00
Upside vs current price+135.9%

The average target of $23.50 is +135.9% versus the current VIR price of $9.96.

Vir Biotechnology, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy6
Hold0
Sell0
Strong sell0
ConsensusBuy

9 analysts cover VIR.

Vir Biotechnology, Inc. EPS and revenue estimates

The estimate table for the Vir Biotechnology, Inc. keeps 2026 EPS $-1.78, 2027 EPS $-2.54, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-1.78$246.03M
2027$-2.54$73.41M

Is Vir Biotechnology, Inc. a buy or sell?

Of the 9 analysts covering Vir Biotechnology, Inc., 9 rate it a buy (3 strong buy and 6 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The VIR consensus label is Buy, beside 9 buy-side ratings and 0 sell-side ratings.

The average target of $23.50 implies +135.9% versus the current price of $9.96.

the Vir Biotechnology, Inc. closes with 9 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Vir Biotechnology, Inc. forecast

There is little daylight between VIR targets. Low $22.00, average $23.50, high $25.00.

From today's $9.96 print, the VIR average target is +135.9% away.

Most of the VIR coverage agrees: 9 of 9 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

VIR targets have eased: $22.00 in the last month against $23.50 over the last quarter.

VIR coverage is thin at 9 analysts, and one revision moves the average.

Vir Biotechnology, Inc. forecast questions

What is the VIR price target?

The published range for VIR is $22.00 to $25.00, with an average of $23.50. That average is +135.9% versus the current price of $9.96.

Is Vir Biotechnology, Inc. a buy or sell?

Of the 9 analysts covering Vir Biotechnology, Inc., 9 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for VIR is 9 on the buy side, 0 at hold, and 0 on the sell side.

What is the EPS estimate for Vir Biotechnology, Inc.?

Analyst EPS estimates for Vir Biotechnology, Inc.: 2026 $-1.78, 2027 $-2.54.

What is the revenue estimate for Vir Biotechnology, Inc.?

Analyst revenue estimates for Vir Biotechnology, Inc.: 2026 $246.03M, 2027 $73.41M.

How many analysts cover VIR?

9 analysts cover VIR. Their consensus on VIR is Buy, across those 9.

VIR price $9.96 -2.16 -17.82%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener